Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more that one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine and docetaxel in
treating patients who have locally advanced or metastatic cancer of the pancreas.